Related Experiment Video
Updated: Aug 19, 2026

Measurement of Heme Synthesis Levels in Mammalian Cells
Published on: July 9, 2015
Binding of chemical carcinogens and mutagens to rat hemoglobin
Abstract:
The alkylation of hemoglobin is a proposed dose monitor for chemical carcinogens and mutagens. The binding of fifteen chemical carcinogens and mutagens to rat hemoglobin was determined. Direct acting carcinogens and indirect acting carcinogens including aromatic amines, halogenated hydrocarbons, nitrosamines, polycyclic aromatic hydrocarbons, aflatoxin B1 and benzene bound hemoglobin. The efficiency of carcinogen and mutagen hemoglobin was dose dependent and ranged from 0.007 to 2.3% of an oral dose. The binding of chemical carcinogens and mutagens to hemoglobin would appear to be generic so that it could be developed into a dose monitor for a large number of known carcinogens and mutagens.
Related Concept Videos
Physical Properties of Amines
Mutagenicity and Carcinogenicity
Hemoglobin
When all four heme groups are bound to oxygen, the resulting molecule is called oxyhemoglobin. As a result, arterial blood...
Bioactivation and Tissue Toxicity
Toxicity Testing in Animals
Spontaneous and Induced Mutations

